Diagnostics

  • Clinical Diagnostic Triad:
      1. Severe acute liver injury (AST & ALT typically > 1000 U/L).
      1. Signs of hepatic encephalopathy.
      1. INR ≥ 1.5 (synthetic dysfunction).
    • Constraint: Must occur in a patient without pre-existing cirrhosis or chronic liver disease, with a disease duration < 26 weeks.
  • Initial/Screening Labs:
    • PT/INR (most important prognostic marker).
    • LFTs (AST, ALT, Bilirubin, ALP).
    • Serum acetaminophen level (mandatory in all cases of ALF).
    • Toxicology screen.
    • Viral serologies (HAV IgM, HBsAg, HBcAb IgM, HCV Ab, HEV IgM).
    • Autoimmune markers (ANA, ASMA, IgG).
    • Ceruloplasmin and copper levels (if Wilson disease suspected).
    • Pregnancy test (rule out HELLP syndrome or acute fatty liver of pregnancy).
  • Imaging:
    • RUQ Ultrasound with Doppler: Initial modality of choice to rule out biliary obstruction and assess hepatic/portal vein patency (exclude Budd-Chiari).
  • Confirmatory/Gold Standard:
    • Diagnosis is primarily clinical based on the triad. Liver biopsy is rarely required and should only be performed via the transjugular route due to severe coagulopathy.